NCT02408445View on ClinicalTrials.gov

Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 8, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 1, 2020

Conditions
Klinefelter Syndrome
Interventions
DRUG

testosterone cypionate 200mg/ml

Subjects in this group will be randomized to receive testosterone cypionate 200 mg/ml to be given intramuscularly every 4 weeks for a total of 3 doses.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02408445 - Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment | Biotech Hunter | Biotech Hunter